Table 3.
Time Period | Averaged Overall All Strains, All Years | Pandemic H1N1 Only | |||||
---|---|---|---|---|---|---|---|
n | % Seroconverted* | Odds Ratio† 95% CI | n | % Seroconverted* | Odds Ratio†† 95% CI | ||
First trimester (less than 13 weeks) | 73 | 54.8 | 0.48 (0.16, 1.41) | 7 | 28.6 | 0.27 (0.03, 2.12) | |
Second trimester (13-less than 28 weeks) | 183 | 62.8 | 0.76 (0.29, 2.05) | 16 | 62.5 | 1.11 (0.22, 5.62) | |
Early third trimester (28-less than 34 weeks) | 86 | 58.1 | 0.74 (0.26, 2.14) | 10 | 60.0 | 1.00 (0.17, 5.98) | |
Late third trimester (34 weeks or more) | 56 | 69.6 | 1.41 (0.43, 4.58) | 8 | 87.5 | 4.67 (0.40, 53.95) | |
Immediate postpartum (less than 72 hours) | 73 | 54.8 | 0.55 (0.18, 1.71) | 3 | 66.7 | Ref | |
Later postpartum (approximately 6 weeks) | 36 | 69.4 | ref | 7 | 57.1 |
CI, confidence interval.
Crude seroconversion rate averaged over all strains and separately for pandemic H1N1
Adjusted for strain, baseline antibody titer, vaccination in the last year, age at vaccination, education, and obesity.
Unadjusted